Search

Dear Metabolic Families,

Having improved our line of Metabolic formulas to be in line with the latest nutritional guidelines we will no longer supply our lines of Maxamaid and Milupa products after June of 2017 or until supplies last.

At Nutricia North America, we work very hard to ensure metabolic patients receive the best possible nutritional support. The past couple of years have been exciting as we have enhanced our product portfolio to grow with patients from infancy to adulthood. We proudly introduced our Periflex® / Anamix® Early Years line for infants with the added benefits of DHA & ARA and prebiotic fiber to be closer to breast milk than ever before*! In addition, we launched the follow-on formulas Periflex® Junior Plus and Anamix® Next, which contain added DHA & a multi-fiber blend.

Although we are confident that these changes are in the best interest of metabolic patients, we certainly understand the challenges that may come with transitioning to new formula. If you are currently using a Maxamaid or Milupa formula please follow the steps below to start your transition:
  1. Contact your clinic/healthcare professional to find other products within our portfolio and start the transition process. Please do not initiate a transition on your own.
  2. If you have questions regarding insurance reimbursement, contact our Reimbursement Care team Monday – Friday 8:30am – 5:00pm EST at 1-800-605-0410.
  3. If you have product related questions or need help finding a supplier for your new formula , contact our Customer Service team Monday – Friday 8:30am – 5:00pm EST at 1-800-605-0410.
Please know our goal is to provide the best nutrition possible, and we are committed to being the best in specialized nutrition for the metabolic community.

Sincerely,

The Nutricia Metabolic Team

* Compared to Nutricia’s Periflex Infant and Analog formulas



CHANGE THE LIVES OF MSUD ADULTS AND CHILDREN

The MSUD Family Support Group is currently funding several research projects and we are proactively looking for researchers interested in developing new treatments or finding a cure for MSUD. Significant funding is necessary if we are to accomplish this goal.
Donate Today Learn More

Subscribe to our mailing list

Signup To Our E-Blast Signup with your email address to receive our e-blast newsletter.